跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Odrisof - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Odrisof
Approved
STANDARD
Odrisof
Interphil Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9e4a6f01e9c009c0
Company
Interphil Laboratories Inc.
Type
Standard
Approval Details
Approval Id
9e4a6f01e9c009c0
Drug Approval Philippines Name
Odrisof
Product Name
Odrisof
Registration Number
DRP-3612-02
Brand Name
Odrisof
Generic Name
Ibuprofen + Paracetamol
Dosage Form
Capsule
Dosage Strength
200 mg/ 325 mg
Manufacturer
Interphil Laboratories Inc.
Distributor
Audrey Pharma Inc
Issuance Date
27 June 2022
Expiry Date
26 July 2027
Pharmacologic Category
Analgesic/Antipyretic
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9e4a6f01e9c009c0
Type
Standard
Back to Philippines FDA Approvals